IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4+ T cells and promoting CTL persistence in a murine model of plasmacytoma.

Wang L, Liu JQ, Talebian F, Liu Z, Yu L, Bai XF
Oncoimmunology 4 e1014232 07/01/2015

Abstract

Interleukin-10 (IL-10) is a potent anti-inflammatory cytokine that regulates immune responses. IL-10 has also been shown to enhance antitumor CD8

Full Text